NCT07159334

Brief Summary

This study is being conducted at the Department of General Surgery, King Edward Medical University, Lahore, Pakistan. The purpose of the trial is to compare the effectiveness of topical Lignocaine ointment versus topical Glyceryl Trinitrate (GTN) ointment in reducing postoperative pain following hemorrhoidectomy. Patients undergoing hemorrhoidectomy will be randomly assigned to receive either Lignocaine ointment or GTN ointment applied locally after surgery. Pain relief will be assessed using a visual analog scale (VAS) at regular intervals during the postoperative period. The study aims to determine which ointment provides better pain control and improves patient comfort during recovery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2025

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

August 21, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 8, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

August 21, 2025

Last Update Submit

September 3, 2025

Conditions

Keywords

HemorrhoidectomyLignocaine ointmentGlyceryl Trinitrate ointmentAnal pain

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain score

    Pain intensity will be assessed using the Visual Analogue Scale (VAS), which ranges from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.

    Up to 1 month postoperatively.

  • Wound Healing Time

    Defined as the number of days from the date of surgery until complete wound healing (full epithelialization with no discharge or open area). Shorter duration indicates a better outcome.

    Up to 1 month postoperatively.

Secondary Outcomes (7)

  • patient Satisfaction Level

    6 weeks postoperatively

  • Time to Request of First Analgesic Dose

    Within 24 hours postoperatively

  • Amount of Analgesia Administered in First 24 Hours

    0-24 hours postoperatively

  • Incidence of Wound Secretion

    1 month postoperatively

  • Incidence of Itching

    1 month postoperatively

  • +2 more secondary outcomes

Study Arms (2)

1.Lignocaine Ointment Group

EXPERIMENTAL

Participants will receive topical lignocaine ointment applied to the anal wound post-hemorrhoidectomy for pain control.

Drug: Lignocaine OintmentDrug: Glyceryl Trinitrate Ointment 0.2%

Glyceryl Trinitrate Ointment Group

EXPERIMENTAL

Participants will receive topical 0.2% glyceryl trinitrate ointment applied to the anal wound post-hemorrhoidectomy for pain control.

Drug: Lignocaine OintmentDrug: Glyceryl Trinitrate Ointment 0.2%

Interventions

Applied to the anal wound three time daily after hemorrhoidectomy.

1.Lignocaine Ointment GroupGlyceryl Trinitrate Ointment Group

Applied to the anal wound three time daily after hemorrhoidectomy.

1.Lignocaine Ointment GroupGlyceryl Trinitrate Ointment Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 - 60 years
  • Both genders
  • Grade III and IV hemorrhoids diagnosed on the basis of history and clinical examination by consultant Surgeon.(Grade III Hemorrhoid manually reduced by patient with finger and Grade IV is prolapsed)
  • ASA (American society of Anesthesia) grades I, and II

You may not qualify if:

  • Previously reported allergy or reaction to lignocaine and GTN
  • Pregnancy or lactation
  • Concomitant perianal pathology warranting surgery
  • Cardiovascular disease
  • Patient taking Nitrates or Calcium channel blocker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Edward Medical uUniveristy Mayo Hospital

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

MeSH Terms

Conditions

HemorrhoidsPain, Postoperative

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Hafiz Ahmad Rauf

    King Edward Medical University/Mayo hospital Lahore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hafiz Ahmad Rauf, Mbbs,Fcps

CONTACT

KEMU/ Mayo Hospital lahore

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: "Participants will be randomized into two parallel groups: one receiving topical lignocaine ointment and the other receiving topical glyceryl trinitrate ointment for postoperative pain management after hemorrhoidectomy."
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2025

First Posted

September 8, 2025

Study Start

August 2, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

September 8, 2025

Record last verified: 2025-09

Locations